Search

everythinglearnresearchcommunity

for

Search:↓

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Mogamulizumab, a skin cancer drug, may cause hair loss similar to alopecia areata.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

Retinol may affect immune responses in people with frequent skin boils.

Combining glucocorticoids with immunosuppressants like cyclophosphamide improves remission and reduces relapse in pemphigus patients.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

Aging and chronic inflammation weaken the immune system, increasing cancer and infection risks.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Certain microRNAs may protect against hair loss in alopecia areata and could be potential treatment targets.